Despite physiological conditions, substantial evidence has suggested that pathogenic variants in ATP1A3 are potential causes of various neurological disorders (Smedemark-Margulies et al., 2016; Salles et al., 2021; Vezyroglou et al., 2022). The gene discussed is ATP1A3; the disease is nervous system disorder.